Search for "SEC Live Filings Digest" to find out more.
Natus Medical (BABY) reduced its second quarter guidance, expecting now to report $81M to $82M in revenue instead of the projected $86M to $90M originally forecasted. Natus President and CEO Jim Hawkins remarked that international business in Europe resulted in less-than-expected earnings, while performance in the United States was as expected. With these results the company will update its third quarter guidance in addition to its full annual expectations. The company had experienced a good start to the year with its stock price rising 28% through Friday and, as reported in Filings Digest May 9, 2013, first quarter revenues exceeded analyst expectations by $1M to $2M.